Ractigen Therapeutics, a clinical-stage biotechnology company pioneering RNA activation (RNAa) therapeutics, today announced that first-in-human findings from its RAG-18 program in Duchenne muscular ...

Add Yahoo as a preferred source to see more of our stories on Google. When Conner Curran was first diagnosed with Duchenne muscular dystrophy at age 4, his parents were told there was nothing they ...

Under the agreement, Modalis will be granted rights to utilise EMC181 in the development of MDL-201.

A rehabilitation center for children with Duchenne muscular dystrophy will be established in Tbilisi, Mayor Kakha Kaladze announced at a ...

The "Duchenne Muscular Dystrophy - Market Insight, Epidemiology, Forecast - 2036" has been added to ResearchAndMarkets.com's offering. The Duchenne muscular dystrophy (DMD) market reached ...

New research led by the University of Portsmouth has revealed how Duchenne muscular dystrophy (DMD), best known for causing severe muscle degeneration, also profoundly affects the brain, leading to ...

Gene therapy may have the potential to cure Duchenne muscular dystrophy, but early results from clinical trials have not been as promising as researchers hoped. Research is ongoing. Duchenne muscular ...

Duchenne muscular dystrophy (DMD) is the most common muscular dystrophy diagnosed in childhood, with approximately 20,000 new cases reported each year. It is a progressive muscle disorder that results ...

An Orlando child with Duchenne muscular dystrophy got a new power wheelchair through the Wheelchairs 4 Kids program.

An update from Satellos Bioscience ( ) is now available. On September 9, 2026, Satellos Bioscience announced that its lead drug candidate SAT-3247 has been assigned the Internatio ...